Intervacc AB (publ) (STO:IVACC)
1.340
+0.066 (5.18%)
Jun 11, 2026, 5:29 PM CET
Intervacc AB Employees
Intervacc AB had 15 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
1.19M SEK
Profits / Employee
-5.59M SEK
Market Cap
456.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 2 | 15.38% |
| Dec 31, 2021 | 13 | 1 | 8.33% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 75 |
| Sprint Bioscience AB | 30 |
| Mendus AB | 27 |
| Xspray Pharma AB | 24 |
| Cantargia AB | 22 |
| Corline Biomedical AB | 13 |
| Ascelia Pharma AB | 10 |
| AlzeCure Pharma AB | 10 |
Intervacc AB News
- 4 weeks ago - Intervacc AB Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Intervacc AB (OSTO:IVACC) Q1 2026: Everything You Need to Know Ahead of Earnings - GuruFocus
- 4 months ago - Intervacc AB Annual report: Q4 2025 - Filings
- 4 months ago - Intervacc AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Earnings To Watch: Intervacc AB (OSTO:IVACC) Reports Q4 2025 Result - GuruFocus
- 6 months ago - Intervacc AB Transcript: DNB Carnegie Småbolagsdag - Transcripts
- 7 months ago - Intervacc AB Quarterly report: Q3 2025 - Filings
- 7 months ago - What To Expect From Intervacc AB (OSTO:IVACC) Q3 2025 Earnings - GuruFocus